Real-world treatment patterns and outcomes by mismatch repair/microsatellite instability (MMR/MSI) status in patients (pts) with advanced endometrial cancer (aEC), 2018-2023.

被引：0
|
作者：
Pothuri, Bhavana
Thaker, Premal H.
Tymejczyk, Olga
Reiss, Samantha
Nitti, Giovanni
Cain, Theresa
Hada, Manila
机构：
[1] NYU Langone Hlth, Div Gynecol Oncol, Dept Obstet & Gynecol, New York, NY USA
[2] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA
[3] Flatiron Hlth Inc, New York, NY USA
[4] AstraZeneca, Gaithersburg, MD USA
[5] AstraZeneca, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5601
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Testing patterns for microsatellite instability & mismatch repair deficiency in gastrointestinal cancers: Real-world evidence from a tertiary care cancer center
    Kandula, M. R.
    Pinninti, R.
    Rajappa, S. J.
    Kodandapani, S.
    Rao, T. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S203 - S204
  • [22] Rates of genotyping for KRAS, NRAS, BRAF, microsatellite instability (MSI), and mismatch repair (MMR) in metastatic colon cancer patients: Gaps and implications.
    Gutierrez, Martin
    Price, Kristin Sedgwick
    Lanman, Richard B.
    Nagy, Rebecca
    Shah, Irfan
    Mathura, Shivam
    Norden, Andrew David
    Goldberg, Stuart L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Prognostic significance of microsatellite instability (MSI) and mismatch repair status (MMR) in African American (AA) patients with colorectal cancer (CRC) and its impact on therapy with 5Fluorouracil.
    Bari, Shahla
    Balan, Shuba
    Adamson, Paula
    Merchant, Ambreen
    Nutalapati, Snigdha
    Ajose, Taiwo
    Kagbokue, Suaka
    Jain, Sanjay R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Patient characteristics and treatment patterns in patients with advanced or recurrent endometrial cancer in Europe: A real-world study
    Shen, Qin
    Hunger, Matthias
    Pahwa, Ankit
    Schade, Rene
    Boklage, Susan
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S178 - S178
  • [25] Efficacy of immune checkpoint blockade in patients with advanced upper tract urothelial cancer and mismatch repair deficiency or microsatellite instability (MSI).
    Andreev-Drakhlin, Alexander
    Shah, Amishi Yogesh
    Adriazola, Ana Cecilia
    Shaw, Leah
    Lopez, Lidia
    James, Marihella
    Matin, Surena F.
    Alhalabi, Omar
    Gao Jianjun
    Siefker-Radtke, Arlene O.
    Goswami, Sangeeta
    Xiao Lianchun
    Venkatesan, Aradhana M.
    Campbell, Matthew T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [26] Updated results of activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601)
    Antill, Y.
    Kok, P. S.
    Stockler, M. R.
    Robledo, K.
    Yip, S.
    Parry, M.
    Smith, D.
    Spurdle, A.
    Barnes, E.
    Friedlander, M. L.
    Baron-Hay, S.
    Shannon, C.
    Coward, J.
    Beale, J.
    Goss, G.
    Meniawy, T.
    Andrews, J.
    Kelly, M.
    Mileshkin, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] Real-world efficacy and safety of immune checkpoint inhibitors (ICI) in gastrointestinal tumors with mismatch repair deficiency or microsatellite instability (dMMR/MSI-H)
    Martinez Lago, N.
    Cousillas, A.
    Jara, P.
    Reboredo Lopez, M.
    Gonzalez Villarroel, P.
    Covela, M.
    Lopez, C.
    Grana Suarez, B.
    Gallardo Martin, E.
    de la Camara Gomez, J.
    Garcia Lorenzo, C.
    Lopez Jato, C.
    Carral Maseda, A.
    Fernandez Montes, A.
    Rivera Herrero, F.
    ANNALS OF ONCOLOGY, 2024, 35 : S206 - S206
  • [28] Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H)
    Liao, Ying
    Zhu, Changhua
    Song, Xiaoxia
    Ruan, Jiugen
    Ding, Yao
    Chen, Yuan
    Yang, Qiujuan
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [29] Retrospective review of endometrial cancer (EC) specimens in individuals younger than age 50 for microsatellite instability (MSI) testing and DNA mismatch repair enzyme (MMR) expression.
    Nugent, W.
    Durie, N.
    Palaia, T.
    Ragolia, L.
    Hanna, I.
    Staszewski, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Real-world treatment patterns and outcomes in patients (pts) with advanced, ALK plus non-small cell lung cancer (NSCLC) in Europe
    Stoyanov, N.
    Anderson, D.
    Combest, A.
    Nguyen, B.
    Ognar, R.
    Reitsma, D.
    Capart, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S860 - S860
12345